Encompass Health price target raised to $74 from $69 at Mizuho

Mizuho analyst Ann Hynes raised the firm’s price target on Encompass Health to $74 from $69 and keeps a Buy rating on the shares. The analyst increased estimates following the "strong" Q1 results. The guidance raise appears conservative, particularly around assumptions for no further improvement to contract labor pressures this year, the analyst tells investors in a research note.